Glenohumeral osteoarthritis (OA) is a disabling disease that leads to poor shoulder function and pain. Primary or idiopathic osteoarthritis occurs in previously intact joints without any inciting agent. Its precise incidence is not known. If conservative treatment fails, there are a variety of surgical procedures described in the literature.Total shoulder arthroplasty (TSA) is primarily indicated in patients above 60 years old with symptomatic glenohumeral OA and intact rotator cuff and failed conservative treatment. However, it is rarely recommended to young or active patients under the age of 50 due to its increased morbidity, limited lifespan, potential for revision surgeries, and difficulty achieving the same preoperative activity level, particularly in patients with high preoperative level of activity.Comprehensive arthroscopic management (CAM), hemiarthroplasty (HA), and TSA provide good results even in the long term for treatment of primary OA in properly selected young patients.A CAM procedure seems to be a reasonable option in case of conservative treatment failure, localized cartilage defect, tendinopathy of the long head of the biceps, stiffness, inferior osteophytes, and humeral head congruity.However, in case of humeral head incongruity, large anterior osteophytes, and an intact rotator cuff, an HA or a TSA is a feasible option.
A 40-year-old man, after a left acetabular fracture, had eight surgeries, suffered from chronic multidrug-resistant infection with fistula, and underwent multi-stage hip revision surgery with spacer exchange and reconstruction, combined with systemic and intra-articular antibiotic therapy. He remained infection-free at 3.5-year follow-up.
Introduction & Aim Periprosthetic joint infection (PJI) is one of the most devastating complications, with an incidence rate of around 2% after total knee arthroplasty (TKA). According to different arthroplasty registries, PJI is the most common reason for a revision surgery of TKA. The major concern related to unicompartmental knee arthroplasty (UKA) compared to TKA is the inferior long-term survival reported. Some novel cohort studies report that UKA is associated with a lower risk of PJI compared to TKA, but none of the studies available compared the success rate of PJI treatment after UKA and TKA. The present study aimed to compare the risk for PJI within first 2 years after UKA and TKA. Methods We retrospectively analyzed a consecutive cohort of patients between 2010 and 2023 having cemented UKA or TKA at a high-volume orthopaedic hospital. For each procedure, the demographic data about the patient, date of primary arthroplasty, date of revision surgery, reason for revision surgery, date of death, and date of last follow-up were collected prospectively. The primary outcome was revision due to PJI within first 2 years after the surgery. The definite diagnosis of PJI was based on the EBJIS definition. The rate of PJI in the UKA and TKA was compared. Results In total, 1,492 cemented, fixed-bearing UKA and 8,007 cemented TKAs were included. UKA and TKA subgroup were similar age, sex distribution and BMI. Among UKAs, we identify 6 PJI (0.5%), while 121 PJI (1.5%) among TKAs (p<0.001). Considering UKA PJI, we observed 3 early infections, all successfully cured with debridement, exchange of polyethylene liner, irrigation, and antibiotic course (DAIR). The remaining 3 late infections were successfully cured with one-stage conversion (OSE) to TKA followed by antibiotic treatment. Considering TKA PJI, we observed 39 early PJI and 82 late PJI. Among early TKA PJI, 22 were treated with DAIR and 17 with two-stage implant exchange (TSE) with 4 cases of PJI treatment failure. Among late TKA PJI, 33 were treated with DAIR, 10 with OSE, and 39 with TSE. Among all TKAs, 88% success rate of PJI treatment was observed, 8 failures were observed in the DAIR procedure after late acute PJI, and 7 failures after the TSE protocol, while no failure of OSE. Conclusions Our study shows that UKA is associated with lower risk for PJI than TKA. Furthermore, we also observed a higher success rate of PJI treatment in UKA compared to TKA.
Background and Objectives: Cementless total knee arthroplasty (TKA) with two-pegged Trabecular Metal (TM) tibial components composed of porous tantalum was introduced to improve fixation and reduce aseptic implant failure, particularly in younger, more active patients. Despite these theoretical advantages, mid-term outcomes remain uncertain. This retrospective study compares the survival of consecutive cementless TKAs with TM posterior-stabilized (PS) and cruciate-retaining (CR) modular tibial components with cemented PS and CR components from the same implant system, using revision for aseptic causes as the primary endpoint. Materials and Methods: Institutional review board approval was obtained, and a minimum follow-up of two years was required. Between January 2017 and November 2021, a total of 1202 TKAs of a single implant design were performed at a high-volume academic center by five board-certified orthopedic surgeons, predominantly for primary osteoarthritis. Of these, 826 (68.7%) procedures were cemented, and 376 (31.3%) were cementless. Demographic data and revision outcomes were collected for all patients. Results: There was no statistically significant difference between cohorts in the 7-year survival rate for all causes of revision (97.4%, 95% CI 95.6-99.2 for cementless vs. 97.8%, 95% CI 96.6-99.0 for cemented; p = 0.63). However, the 7-year survival rate for aseptic causes was significantly lower (p < 0.05) in the cementless TKA group (97.9%, 95% CI 96.3-99.5) compared with the cemented group (99.4%, 95% CI 98.8-100). Revisions for aseptic causes occurred in 7 cementless (1.86%) and 4 cemented (0.84%) TKAs (p < 0.05), most commonly due to loosening of the tibial TM component (6 [1.59%] vs. 2 [0.24%], respectively; p < 0.05). During follow-up, 94 patients (8.7%) died of causes unrelated to TKA. Conclusions: Cementless TM PS and CR modular TKAs demonstrated inferior mid-term performance compared with their cemented counterparts for aseptic reasons. These findings raise concerns regarding the durability of this cementless design and underscore the need for cautious use and further investigation.
The increasing number of joint replacement surgeries has led to an increase in periprosthetic joint infections (PJI). Chronic PJI caused by Staphylococcus epidermidis is very common and challenging to treat, prompting interest in bacteriophage therapy. Preclinical studies are essential for optimizing phage administration routes and dosages. Here, phage replication and bacterial growth inhibition using phage and vancomycin were first assessed in vitro. Then, chronic PJI was induced in mice using biofilm-coated titanium implants inoculated with S. epidermidis COB-SE3 to evaluate the efficacy of phage COP-80B and vancomycin therapy. Mice received one intra-articular and two intraperitoneal phage doses over three days, along with vancomycin administered twice daily for five days. Four weeks after implantation, we quantified and compared bacterial loads in periarticular tissues and implants across four groups: untreated controls, phage monotherapy, vancomycin monotherapy, and phage-vancomycin combination. Infection persistence was lower than expected, limiting the ability to detect treatment effects and assess therapeutic efficacy in this low-virulence model. Intra-articular administration of 1010 PFU of COP-80B did not alter plasma alanine aminotransferase levels, indicating no hepatotoxicity. Bacterial isolates remained susceptible to both phage and vancomycin, while phage-neutralizing antibodies developed during treatment. Overall, this study evaluates phage-vancomycin therapy while also contributing a murine model that advances methodological development for chronic S. epidermidis PJI research, with additional refinement of infection kinetics needed to reliably assess therapeutic efficacy.